Rowland Carmichael Advisors’s Quest Diagnostics DGX Stock Holding History

Rowland Carmichael Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$479K	Hold	4,018	–	–	0.15%	147
2020 Q3	$460K	Hold	4,018	–	–	0.18%	134
2020 Q2	$458K	Hold	4,018	–	–	0.19%	132
2020 Q1	$323K	Hold	4,018	–	–	0.16%	156
2019 Q4	$429K	Hold	4,018	–	–	0.15%	165
2019 Q3	$430K	Buy	4,018 +18	+0.5%	+$1.85K	0.15%	166
2019 Q2	$407K	Hold	4,000	–	–	0.14%	166
2019 Q1	$360K	Hold	4,000	–	–	0.13%	174
2018 Q4	$333K	Hold	4,000	–	–	0.15%	163
2018 Q3	$432K	Hold	4,000	–	–	0.17%	150
2018 Q2	$440K	Hold	4,000	–	–	0.19%	145
2018 Q1	$401K	Hold	4,000	–	–	0.22%	140
2017 Q4	$394K	Hold	4,000	–	–	0.2%	146
2017 Q3	$375K	Sell	4,000 -95	-2%	-$10.1K	0.21%	148
2017 Q2	$455K	Buy	4,095 +95	+2%	+$10K	0.26%	121
2017 Q1	$393K	Hold	4,000	–	–	0.24%	126
2016 Q4	$368K	Hold	4,000	–	–	0.22%	140
2016 Q3	$339K	Hold	4,000	–	–	0.22%	139
2016 Q2	$326K	Sell	4,000 -620	-13%	-$47.2K	0.21%	146
2016 Q1	$330K	Buy	+4,620	New	+$310K	0.3%	105

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rowland Carmichael Advisors's DGX Position: Q4 2020 in Review

Rowland Carmichael Advisors held its Quest Diagnostics (DGX) position steady in Q4 2020 at 4,018 shares worth $479K. The position accounts for 0.15% of the portfolio, ranked #147.

Rowland Carmichael Advisors first reported a position in DGX in Q1 2016 and has held it in 20 quarters since. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

Rowland Carmichael Advisors held 4,018 shares of Quest Diagnostics worth $479K as of Q4 2020.
Rowland Carmichael Advisors left its Quest Diagnostics share count unchanged in Q4 2020.
Quest Diagnostics made up 0.15% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #147 holding.
Rowland Carmichael Advisors first reported a position in Quest Diagnostics in Q1 2016 and has held it in 20 quarters since.
811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.